MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Rucaparib hydrochloride

CAS No. : 773059-19-1

MCE 站：Rucaparib hydrochloride

产品活性：Rucaparib (AG014699) hydrochloride 是一种口服有效的 PARP 蛋白 (PARP-1, PARP-2 ａnd PARP-3) 抑制剂，对 PARP-1 的 K_i 为 1.4 nM。Rucaparib hydrochloride 是六磷酸己糖脱氢酶 (H6PD) 抑制剂。Rucaparib hydrochloride 具有用于去势抵抗性前列腺癌 (CRPC) 研究的潜力。

研究领域：Cell Cycle/DNA Damage  |  Epigenetics

作用靶点：PARP

In Vitro: Rucaparib (AG014699) hydrochloride is a possible N-demethylation metabolite of AG14644.
Rucaparib (0.1, 1, 10, 100 μM; 24 hours) hydrochloride is cytotoxic ａnd has the LC₅₀ being 5μM in Capan-1 (BRCA2 mutant) cells ａnd only 100nM in MX-1 (BRCA1 mutant) cells.
The radio-sensitization by Rucaparib hydrochloride is due to downstream inhibition of activation of NF-κB, ａnd is independent of SSB repair inhibition. Rucaparib hydrochloride can target NF-κB activated by DNA damage ａnd overcome toxicity observed with classical NF-κB inhibitors without compromising other vital inflammatory functions.
Rucaparib hydrochloride inhibits PARP-1 activity by 97.1% at a concentration of 1 μM in permeabilised D283Med cells.

In Vivo: Rucaparib (AG014699) hydrochloride ａnd AG14584 significantly increase Temozolomide toxicity. Rucaparib (1 mg/kg) hydrochloride significantly increases Temozolomide-induced body weight loss. Rucaparib (0.1 mg/kg) hydrochloride results in a 50% increase in the temozolomide-induced tumor growth delay.
Rucaparib (10mg/kg for i.p. or 50, 150 mg/kg for p.o.; daily for 5 days per week for 6 weeks) hydrochloride significantly inhibits the growth of the tumor, ａnd there is one complete tumor regression ａnd two persistent partial regressions.
Rucaparib (150mg/kg; p.o.; once per week for 6 weeks or three times per week for 6 weeks) hydrochloride has greatest antitumor effect with three complete regressions.
Rucaparib (1 mg/kg; i.p.; daily for 5d) hydrochloride enhances the antitumor activity of temozolomide ａnd indicates complete ａnd sustained tumor regression in NB1691 ａnd SHSY5Y xenografts.

相关产品：Olaparib  |  XAV-939  |  Talazoparib  |  Niraparib  |  Rucaparib  |  Veliparib  |  AZD5305  |  RBN-2397  |  PJ34  |  Pamiparib  |  Dehydrocorydaline  |  Fucosterol  |  RBN012759  |  G007-LK  |  AG14361  |  Rucaparib monocamsylate  |  3-Aminobenzamide  |  Fluzoparib  |  AZD-2461  |  NVP-TNKS656  |  Iniparib  |  NMS-P118  |  BGP-15  |  Daphnetin

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  染料试剂  |  PROTAC  |  同位素标记物  |  寡核苷酸

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。